Long-term observational study for pediatric brain tumors

JRCT ID: jRCT1050220134

Registered date:15/12/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Pediatric brain tumor
• Date of first enrollment: 25/09/2020
• Target sample size: 1000
• Study type: Observational

Outcome(s)

• Primary Outcome: Overall survival rate at 20 years

Secondary Outcome

Overall survival rates at 5 and 10 years
Progression-free survival rate at 5 and 10 years
Rate of late complications (Neurocognitive, Endroine, Cardiovascular, Fertility, Stroke, etc)
Rate of secondary neoplasms
Social outcomes
Rate and causes of late mortalities

Key inclusion & exclusion criteria

• Age minimum: >=
• Age maximum: < 30age old
• Gender: Both

Include criteria

1) Patients with brain tumors younger than 30 years old at diagnosis (histology is not limited).
2) Registration of the JCCG pediatric solid tumor observation study has been completed at the time of participation in this study.
3) Registration for the other prospective interventional study for pediatric brain tumors conducted by JCCG is completed.
3) At the same time as this study, the patient is enrolled or will be enrolled in a prospective clinical study conducted by the JCCG Brain Tumor Committee.
4) Written informed consent from the patient and/or legally acceptable proxy has been obtained.

• Exclude criteria: Patients who are unable to evaluate the late effects.

Related Information

• Primary Sponsor: Fujisaki Hiroyuki